UR

About

We're a specialized executive search partner that focuses on lower middle market private equity firms. We help PE-backed companies move faster by bringing in leaders who've already scaled exactly the type of business our clients are trying to build. Instead of just looking at impressive resumes, we search for people with the right trajectory - those #2 leaders inside larger platforms who have the scars, systems, and processes from scaling up.

What makes us different is that we're not selling access to a fancy Rolodex. We're building actual execution capability for companies that need to manufacture growth, not just manage what they already have. Our work concentrates in operationally complex sectors like healthcare services and regulated industries where mistakes are costly and leadership gaps show up quickly. The goal is simple: lower your leadership risk, help you hit the ground running, and get you exit-ready faster.

Open roles at Urrly

Explore 1 open positions at Urrly and find your next opportunity.

UR

Private Equity Associate, Investment Team - DC (onsite)

Urrly

Washington, District of Columbia, United States (On-site)

$200K – $250K Yearly2mo ago

Similar private equity firms

AR

ARCHIMED

ARCHIMED is a global private equity firm dedicated exclusively to healthcare industries, founded in 2014 with a singular mission: to accelerate the development of healthcare solutions that benefit patients worldwide. The firm focuses on small-cap and mid-cap growth buyout transactions across eight targeted healthcare sectors - Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, Pharma Services, and Animal & Environmental Health. What sets ARCHIMED apart is its integrated approach combining operational, medical, scientific, and financial expertise, allowing the firm to serve as both a strategic and financial partner to healthcare businesses across Europe, North America, and Asia. With over 200 team members representing 35+ nationalities, ARCHIMED manages €8 billion across its funds and has invested in more than 80 companies representing over €50 billion in combined value. The firm's strategy is built on a proprietary market segmentation called MedSeg, which splits healthcare industries into 400+ sub-sectors that are individually assessed and prioritized. ARCHIMED's transatlantic platform supports portfolio companies through internationalization, innovation, M&A, and operational excellence. The firm delivers superior returns to investors - all ARCHIMED funds rank as top-decile performers - while maintaining a strong commitment to impact investing through its EURÊKA Foundation, which returns 5% of carried interest profits to the community.

TP